NCT05789589 2026-03-04
ADORATION
Baptist Health South Florida
Phase 1/2 Recruiting
Clinical Trials
8 trialsNCT05635734 2026-02-05
Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma
Cantex Pharmaceuticals
Phase 1/2 Active not recruiting
NCT06724926 2026-01-02
Concurrent Azeliragon With Craniospinal Irradiation
NYU Langone Health
Phase 1 Recruiting
NCT05256745 2025-12-24
RAGE
Georgetown University
Phase 1/2 Recruiting
NCT06831526 2025-11-12
Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma
Washington University School of Medicine
Phase EARLY_PHASE1 Recruiting
NCT05773664 2024-09-19
Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma
City of Hope Medical Center
Phase 1 Withdrawn
NCT05986851 2024-09-05
Azeliragon in MGMT Unmethylated Glioblastoma
Cantex Pharmaceuticals
Phase 2 Active not recruiting
NCT05766748 2024-06-14
Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer
Cantex Pharmaceuticals
Phase 1/2 Recruiting